Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
861
-
862
-
863
Phosphopeptides with predicted MAPK site that showed decreased abundance in 1NM-PP1-treated <i>mak-2<sup>Q100G</sup></i> cells.
Published 2014“…</p>3<p>Showed reduced expression in a <i>mak-2<sup>Q100G</sup></i> germlings treated with 1NM-PP1 (19).…”
-
864
Opioid consumption data.
Published 2025“…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
-
865
Prescription data.
Published 2025“…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
-
866
Refill rate by surgical specialty.
Published 2025“…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
-
867
Noncontinuous data on opioid use.
Published 2025“…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
-
868
-
869
-
870
-
871
-
872
-
873
-
874
-
875
-
876
-
877
Trabectedin induced apoptosis in a dose-dependent manner as measured by the Muse™ Annexin V and Dead Cell assay.
Published 2015“…Trabectedin was shown to induce apoptotic cell death in the cancer stem cells mainly with the increase in early apoptosis (green), cells and the apparent decreased in the percentage of live cells. Trabectedin also significantly induced the total apoptotic cells (yellow) in a dose-dependent manner. …”
-
878
20E repressed ILP-mediated cell membrane translocation of HaP60 and HaP110, dephosphorylated HaP60 and HaP110, and decreased their interaction.
Published 2021“…Bar, 50 μm. <b>C.</b> Co-IP assay showed that 20E decreased the HaP60–HaP110 interaction and induced dephosphorylation in cells. …”
-
879
-
880